UK - Department of Health and Social Care (DHSC)
Global Antimicrobial Resistance Innovation Fund (GAMRIF) – InnoVet AMR: Innovative Veterinary Solutions for AMR with IDRC
Project Data Last Updated: 29/06/2021
IATI Identifier: GB-GOV-10-GAMRIF-WP3-InnoVet-AMR
InnoVet-AMR is a partnership between DHSC and the International Development Research Centre (IDRC) aimed at reducing the emerging risk that antimicrobial resistance (AMR) in animals poses to global health and food security. InnoVet-AMR will fund research to develop new animal vaccines and other innovations to fight AMR in livestock (swine and poultry) and aquaculture production, particularly in low- and middle-income countries (LMICs).Description
Through InnoVet-AMR, IDRC and DHSC aim to achieve two main objectives: (1) support research that will identify innovative veterinary solutions, including vaccines and alternative solutions, to reduce the use of antimicrobials in livestock and aquaculture operations in LMICs; (2) build effective partnerships to better coordinate discovery, development and sustainable delivery of affordable innovative veterinary solutions to reduce the use of antimicrobials in livestock and aquaculture operations in LMICs.Description
Projects funded through the Global AMR Innovation Fund (GAMRIF) will primarily benefit people in LMICs, where the burden of drug-resistant infection is greater.
Sector groups as a percentage of total project budget according to the OECD Development Assistance Committee (DAC) classifications.
A comparison across financial years of forecast budget and spend to date on the project.